V006-4041 Screening compound: 2-{[(3,3-diphenylpropyl)[(2-fluorophenyl)methyl]amino]methyl}-N-(2-methoxyethyl)-1,3-thiazole-4-carboxamide

V006-4041 Screening compound: 2-{[(3,3-diphenylpropyl)[(2-fluorophenyl)methyl]amino]methyl}-N-(2-methoxyethyl)-1,3-thiazole-4-carboxamide
V006-4041 Screening compound: 2-{[(3,3-diphenylpropyl)[(2-fluorophenyl)methyl]amino]methyl}-N-(2-methoxyethyl)-1,3-thiazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V006-4041
2-{[(3,3-diphenylpropyl)[(2-fluorophenyl)methyl]amino]methyl}-N-(2-methoxyethyl)-1,3-thiazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V006-4041

Molecular Formula

C30H32FN3O2S (C30 H32 FN3 O2 S)

Compound Name

2-{[(3,3-diphenylpropyl)[(2-fluorophenyl)methyl]amino]methyl}-N-(2-methoxyethyl)-1,3-thiazole-4-carboxamide

IUPAC name

2-{[(33-diphenylpropyl)[(2-fluorophenyl)methyl]amino]methyl}-N-(2-methoxyethyl)-13-thiazole-4-carboxamide

SMILES

COCCNC(c1csc(CN(CCC(c2ccccc2)c2ccccc2)Cc(cccc2)c2F)n1)=O

InChI

InChI=1S/C30H32FN3O2S/c1-36-19-17-32-30(35)28-22-37-29(33-28)21-34(20-25-14-8-9-15-27(25)31)18-16-26(23-10-4-2-5-11-23)24-12-6-3-7-13-24/h2-15,22,26H,16-21H2,1H3,(H,32,35)

InChI Key

BVFDVAOFNFTVFV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19766816

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

517.67

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.909

Distribution Coefficient, logD

5.909

Water Solubility, LogSw

-5.55

Polar Surface Area

46.755

Acid Dissociation Constant (pKa)

13.94

Base Dissociation Constant (pKb)

3.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.70

V006-4041 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V006-4041 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V006-4041?
Check Price and Availability of V006-4041, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V006-4041 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V006-4041
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V006-4041
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V006-4041 available by request